治疗组采用疏血通注射液治疗；
结论：疏血通对急性脑梗死疗效显著。
目的探讨疏血通治疗急性脑梗死的疗效。
Objective to study the therapeutic about the Shuxuetong therapy acute cerebral infarction.
目的：观察疏血通对急性脑梗死的疗效。
Objective: Shuxuetong observation of acute cerebral infarction.
目的研制疏血通胶囊并对其进行质量考察。
ObjectiveTo optimize the quality control of the Shuxuetong Capsule.
结论疏血通注射液治疗急性脑梗死疗效确切。
Conclusions Shuxuetong injection can produce definitive - ly therapeutic effect on acute cerebral infarction.
目的建立测量疏血通注射液氨基酸的有效方法。
OBJECTIVE to establish an effective method for determining Shuxuetong injection.
目的：观察疏血通注射液和醒脑静注射液治疗急性脑梗死的疗效。
The purpose of observation Shuxuetong injection and XNJI the treatment of acute cerebral infarction.
目的探讨疏血通对沙土鼠缺血再灌注脑组织的保护作用及其机制。
Objective to study the protective effect and mechanism of Shuxuetong on gerbil brain tissue in the area of ischemia reperfusion.
方法利用高效液相色谱采用梯度洗脱测定疏血通注射液中的氨基酸。
METHODS Amino acid and peptides in Shuxuetong injection were determined with gradient elution.
目的评估疏血通对髋关节置换手术患者术后血栓调节蛋白（TM）的影响。
Objective To investigate the change of plasma thrombomudolin (PTM) in the patients after hip replacement receiving treatment of Shuxuetong complex.
目的观察急性脑梗死患者使用疏血通注射液治疗后血小板活化指标的变化。
OBJECTIVE to observe changes in the indexes of blood platelet activation of the patients with acute cerebral infarction after treatment with Shuxuetong Injection.
结论本方法精密度高、稳定性好，可作为疏血通注射液质量分析的有效方法。
CONCLUSION the method is accurate, the stability is good, and it can be used to analyze the quality of Shuxuetong injection.
结论疏血通注射液和依达拉奉注射液联合治疗脑梗死后血管性痴呆安全有效。
Conclusion SXT and edaravone injection was safe and effective to treat vascular dementia after cerebral infarction.
结论疏血通注射液具有明显抗凝、促纤溶作用，对急性脑梗死的治疗和预防安全有效。
Conclusion Shuxuetong injection is effective and safe in treatment and prevention of acute cerebral infarction by accelerating fibrinolysis activity and inhibiting coagulation activity.
结论：黄芪注射液联合疏血通治疗老年急性脑梗死效果明显，是一种安全有效的干预措施。
CONCLUSION: Huangqi Injection combined with Shuxuetong are effective and safe in treating aged acute cerebral infarction.
结论：疏血通注射液能促进脑出血时的血肿吸收、血肿周围低密度区缩小和神经功能改善。
Conclusion Shuxuetong injection can promote the absorption of hematoma, reduce the low-density areas surrounding hematomas and improve the neurological function during intracerebral hemorrhage.
结论疏血通注射液具有安全、方便、疗效肯定的优点，是治疗急性缺血性脑血管疾病的有效药物。
Conclusion Shuxuetong injection is advantageous in its safety, convenience and efficacy and is the effective drug for acute ischemic cerebral vascular disease.
结论疏血通注射液联合阿托伐他汀钙片治疗CAS临床疗效好，具有改善脂质代谢的作用，值得临床推广应用。
CONCLUSION The Shuxuetong injection combined with atorvastatin in patients with CAS has better clinical efficacy, can improve lipid metabolism and is worthy of clinical application.
结论：疏血通注射液对急性缺血性脑卒中的微栓子具有预防和治疗作用；tcd栓子自动监测有助于及时发现微栓子、评估药物疗效。
CONCLUSION: Shuxuetong injection has preventive and therapeutic effects on MES of AIS, TCD automatic embolus monitor helps to find MES in time and evaluate the effect of drugs.
前言：为探讨疏血通注射液治疗急性脑梗死瘀血阻络型的疗效，50例病人采用疏血通注射液治疗，观察临床疗效和血液流变学指标的变化。
To observe the clinical effects of "Shuxuetong Injection" in treating acute cerebral infarction of blood-stasis obstruction, 50 subjects were treated with this Injection.
前言：为探讨疏血通注射液治疗急性脑梗死瘀血阻络型的疗效，50例病人采用疏血通注射液治疗，观察临床疗效和血液流变学指标的变化。
To observe the clinical effects of "Shuxuetong Injection" in treating acute cerebral infarction of blood-stasis obstruction, 50 subjects were treated with this Injection.
应用推荐